Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04577742
NCT04577742CompletedNot Applicable

Long-term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy

Federico II University1 site in 1 country350 target enrollmentStarted: February 1, 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
350
Locations
1
Primary Endpoint
To evaluate long-term outcomes in patients underwent brachytherapy for uveal melanoma
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study investigated the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
40 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age older than 40 years
  • •diagnosis of uveal melanoma

Exclusion Criteria

  • •age older than 80 years
  • •No diagnosis of uveal melanoma

Outcomes

Primary Outcomes

To evaluate long-term outcomes in patients underwent brachytherapy for uveal melanoma

Time Frame: Mean follow-up was 4 years (3 months-9 years)

To investigate the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Federico II University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gilda Cennamo

Principal Investigator

Federico II University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Clinical Outcome in UveitisUveitis
NCT01983488Moorfields Eye Hospital NHS Foundation Trust231
Completed
Not Applicable
Trial of Surgical Excision Margins in Thick Primary Melanoma - 2SurgeryTreatment OutcomeMelanoma
NCT03638492Peter Gillgren936
Recruiting
Not Applicable
Retinal Detachment - Demographic and Clinical SurveyRhegmatogenous Retinal Detachment
NCT01845571Medical University of Vienna400
Recruiting
Not Applicable
Clinical Outcomes after Extended Range of Vision Multifocal Intraocular Lens ImplantatioDiseases of the eye and adnexa
KCT0002058Korea University Ansan Hospital20
Unknown
Not Applicable
Researches of Retinal Artery Lesions and Acute Coronary SyndromeAcute Coronary Syndrome
NCT02415452Capital Medical University660